191 related articles for article (PubMed ID: 24101191)
1. High-level expression of CXCR4 in breast cancer is associated with early distant and bone metastases.
Hung CS; Su HY; Liang HH; Lai CW; Chang YC; Ho YS; Wu CH; Ho JD; Wei PL; Chang YJ
Tumour Biol; 2014 Feb; 35(2):1581-8. PubMed ID: 24101191
[TBL] [Abstract][Full Text] [Related]
2. High chemokine receptor CXCR4 level in triple negative breast cancer specimens predicts poor clinical outcome.
Chu QD; Panu L; Holm NT; Li BD; Johnson LW; Zhang S
J Surg Res; 2010 Apr; 159(2):689-95. PubMed ID: 19500800
[TBL] [Abstract][Full Text] [Related]
3. CXCR4 expression in early breast cancer and risk of distant recurrence.
Andre F; Xia W; Conforti R; Wei Y; Boulet T; Tomasic G; Spielmann M; Zoubir M; Berrada N; Arriagada R; Hortobagyi GN; Hung MC; Pusztai L; Delaloge S; Michiels S; Cristofanilli M
Oncologist; 2009 Dec; 14(12):1182-8. PubMed ID: 19939894
[TBL] [Abstract][Full Text] [Related]
4. Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients.
Ibrahim T; Sacanna E; Gaudio M; Mercatali L; Scarpi E; Zoli W; Serra P; Ricci R; Serra L; Kang Y; Amadori D
Clin Breast Cancer; 2011 Dec; 11(6):369-75. PubMed ID: 21764390
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analysis of breast cancer bone metastasis related gene-CXCR4.
Zhang HW; Sun XF; He YN; Li JT; Guo XH; Liu H
Asian Pac J Trop Med; 2013 Sep; 6(9):732-8. PubMed ID: 23827153
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic CXCR4 expression in breast cancer: induction by nitric oxide and correlation with lymph node metastasis and poor prognosis.
Yasuoka H; Tsujimoto M; Yoshidome K; Nakahara M; Kodama R; Sanke T; Nakamura Y
BMC Cancer; 2008 Nov; 8():340. PubMed ID: 19025611
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
Wu W; Qian L; Chen X; Ding B
Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD
J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038
[TBL] [Abstract][Full Text] [Related]
10. Predictors of early distant metastasis in women with breast cancer.
Rosa Mendoza ES; Moreno E; Caguioa PB
J Cancer Res Clin Oncol; 2013 Apr; 139(4):645-52. PubMed ID: 23283528
[TBL] [Abstract][Full Text] [Related]
11. The chemokine receptor CXCR4 as a novel independent prognostic marker for node-positive breast cancer patients.
Parker CC; Kim RH; Li BD; Chu QD
J Surg Oncol; 2012 Sep; 106(4):393-8. PubMed ID: 22473623
[TBL] [Abstract][Full Text] [Related]
12. An isoform of C/EBPβ, LIP, regulates expression of the chemokine receptor CXCR4 and modulates breast cancer cell migration.
Park BH; Kook S; Lee S; Jeong JH; Brufsky A; Lee BC
J Biol Chem; 2013 Oct; 288(40):28656-67. PubMed ID: 23966000
[TBL] [Abstract][Full Text] [Related]
13. Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression.
Yasuoka H; Kodama R; Tsujimoto M; Yoshidome K; Akamatsu H; Nakahara M; Inagaki M; Sanke T; Nakamura Y
BMC Cancer; 2009 Jul; 9():220. PubMed ID: 19580679
[TBL] [Abstract][Full Text] [Related]
14. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
[TBL] [Abstract][Full Text] [Related]
15. Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis.
Liu Y; Ji R; Li J; Gu Q; Zhao X; Sun T; Wang J; Li J; Du Q; Sun B
J Exp Clin Cancer Res; 2010 Feb; 29(1):16. PubMed ID: 20181250
[TBL] [Abstract][Full Text] [Related]
16. The role of CXCR4 in the prediction of bone metastases from breast cancer: a pilot study.
Sacanna E; Ibrahim T; Gaudio M; Mercatali L; Scarpi E; Zoli W; Serra P; Bravaccini S; Ricci R; Serra L; Amadori D
Oncology; 2011; 80(3-4):225-31. PubMed ID: 21734413
[TBL] [Abstract][Full Text] [Related]
17. CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases.
Russell HV; Hicks J; Okcu MF; Nuchtern JG
J Pediatr Surg; 2004 Oct; 39(10):1506-11. PubMed ID: 15486895
[TBL] [Abstract][Full Text] [Related]
18. Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma.
Kato M; Kitayama J; Kazama S; Nagawa H
Breast Cancer Res; 2003; 5(5):R144-50. PubMed ID: 12927045
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of CXCR4 significantly contributes to metastasis and predicts poor clinical outcome in breast cancer.
Yang P; Liang SX; Huang WH; Zhang HW; Li XL; Xie LH; Du CW; Zhang GJ
Curr Mol Med; 2014 Jan; 14(1):174-84. PubMed ID: 24256053
[TBL] [Abstract][Full Text] [Related]
20. Potential role of HER-2; in primary breast tumor with bone metastasis.
Kim R; Arihiro K; Emi M; Tanabe K; Osaki A
Oncol Rep; 2006 Jun; 15(6):1477-84. PubMed ID: 16685382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
